We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Scientists Identify New Risk Factor for Diabetes

By Biotechdaily staff writers
Posted on 20 Oct 2006
In a breakthrough in the study of risk factors associated with type 1 diabetes, scientists have identified a particular variant of a gene that is more common in people with type 1 diabetes.

The breakthrough was announced by the Institute for Systems Biology (ISB, Seattle, Washington, USA), whose researchers identified a gene, ITPR3, associated with type 1 diabetes. More...
The ITPR3 gene regulates calcium flow within cells. The researchers found that one particular variant of ITPR3 is more common in people with type 1 diabetes, which may point to ITPR3 as a cause of the disease. The finding was reported in the October 2006 issue of the American Journal of Human Genetics. Both environmental and genetic factors are thought to contribute to the disease.

"Scientists having been working to understand the genetics of type 1 diabetes for thirty years. We have long known that the human leukocyte antigen [HLA] class II genes play an important role in risk for type 1 diabetes, but other involved genes have remained elusive,” said Jared Roach, M.D., Ph.D.,a senior research scientist at the ISB. "This study begins to examine one of those involved genes.”

The team, co-directed by Dr. Marta Janer, Ph.D., a senior research scientist at the ISB, analyzed genetic data from patients who had participated in the Swedish Childhood Diabetes study and the Diabetes Incidence in Sweden study, both based in Sweden and represented by Dr. Åke Lernmark of the University of Washington (Seattle, USA). The ITPR3 gene has been studied for years in the nervous system but has never been thought to cause diabetes. A number of studies have found that ITPR3 is abundant in pancreatic islets, which are the parts of the pancreas that contain the beta cells, indicating this protein may be important to the function of beta cells and that a defect may make beta cells more susceptible to an autoimmune attack.

At least in Sweden, ITPR3 may account for a significant portion of the previously unknown genetic risk for type 1 diabetes, concluded the researchers. Preliminary estimates suggest that ITPR3 may be responsible for approximately 20% of the cases of type 1 diabetes in Sweden.

ISB seeks to unravel the mysteries of human biology and identify strategies for predicting and preventing diseases such as cancer, diabetes and AIDS. The driving force behind its approach is the integration of biology, computation, and technology. This approach allows scientists to analyze all of the elements in a system rather than one gene or protein at a time.



Related Links:
Institute for Systems Biology

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.